Cliniexperts Research Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 7 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 204.82%
(FY 2023)
- Profit 524.89%
(FY 2023)
- Ebitda 635.80%
(FY 2023)
- Net Worth 348.02%
(FY 2023)
- Total Assets 141.59%
(FY 2023)
About Cliniexperts Research Services
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwini Kumar and Rashmi Verma serve as directors at the Company.
- CIN/LLPIN
U73200DL2017PTC326499
- Company No.
326499
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Cliniexperts Research Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Verma  | Director | 28-Nov-2017 | Current |
| Ashwini Kumar | Director | 28-Nov-2017 | Current |
Financial Performance of Cliniexperts Research Services.
Cliniexperts Research Services Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 204.82% increase. The company also saw a substantial improvement in profitability, with a 524.89% increase in profit. The company's net worth Soared by an impressive increase of 348.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cliniexperts Research Services?
In 2023, Cliniexperts Research Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cliniexperts Services Private LimitedActive 15 years 27 daysAshwini Kumar and Rashmi Verma are mutual person
Cosbotac Naturals Private LimitedActive 8 years 9 monthsAshwini Kumar and Rashmi Verma are mutual person
- Pioneer Retail Private LimitedActive 20 years 9 months
Ashwini Kumar and Rashmi Verma are mutual person
- Pvgexperts Services Private LimitedActive 2 years 5 months
Ashwini Kumar and Rashmi Verma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cliniexperts Research Services?
Cliniexperts Research Services has a workforce of 8 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cliniexperts Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cliniexperts Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
